|
30-d Outcomes
|
| All-cause mortality |
210 (1.6) |
1645 (1.4) |
.03 |
| Cardiac death |
120 (0.9) |
844 (0.7) |
.007 |
| Stroke |
156 (1.2) |
1805 (1.5) |
.004 |
| Aortic valve reintervention |
15 (0.1) |
128 (0.1) |
.81 |
| Life-threatening bleeding, derived |
137 (1.0) |
1137 (0.9) |
.27 |
| Major vascular complication |
129 (0.9) |
1389 (1.1) |
.07 |
| New requirement for dialysis |
48 (0.4) |
384 (0.3) |
.38 |
| New pacemaker without baseline pacemaker |
742 (5.8) |
8988 (7.9) |
<.001 |
| Any readmissions |
1016 (7.8) |
8653 (7.2) |
.02 |
| New onset of atrial fibrillation |
201 (1.7) |
2157 (2.2) |
<.001 |
|
1-y Outcomes
|
| All-cause mortality |
908 (9.9) |
6877 (8.2) |
<.001 |
| Cardiac death |
289 (3.0) |
1931 (2.1) |
<.001 |
| Stroke |
242 (2.2) |
2691 (2.7) |
.003 |
| Aortic valve reintervention |
51 (0.5) |
332 (0.4) |
.02 |
| Life-threatening bleeding, derived |
204 (1.8) |
1549 (1.5) |
.01 |
| Major vascular complication |
152 (1.2) |
1493 (1.2) |
.37 |
| New requirement for dialysis |
89 (0.9) |
619 (0.6) |
.01 |
| New pacemaker without baseline pacemaker |
844 (7.0) |
9925 (9.2) |
<.001 |
| Any readmissions |
2740 (28.2) |
23178 (26.1) |
<.001 |
| New onset of atrial fibrillation |
285 (2.9) |
2929 (3.5) |
<.001 |
